Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gabriella Matera

Showing results (21-30 of 324) with videos related to

Pageof 33
Sort By:
Therapeutic Advances in Respiratory Disease|January 7, 2009
Safety of long-acting beta2-agonists in the treatment of asthmaMario Cazzola, Maria Gabriella Matera
Therapeutic Advances in Respiratory Disease|January 7, 2009
Cough and asthma: the role of inhaled corticosteroids and beta2-agonistsMario Cazzola, Maria Gabriella Matera
Chest|August 7, 2008
To add, or not to add an inhaled corticosteroid in moderate COPD: that is the questionMario Cazzola, Maria Gabriella Matera
Expert Opinion on Pharmacotherapy|October 21, 2014
Triple combinations in chronic obstructive pulmonary disease - is three better than two?Mario Cazzola, Maria Gabriella Matera
Chest|May 4, 2012
Lung blood flow must be considered when prescribing a long-acting β2-agonist/inhaled corticosteroid combinationMario Cazzola, Maria Gabriella Matera
Respiratory Medicine|November 26, 2022
Clinically important deterioration: a composite tool for managing patients with COPDMario Cazzola, Maria Gabriella Matera
Chest|January 14, 2004
Long-acting bronchodilators are the first-choice option for the treatment of stable COPDMario Cazzola, Maria Gabriella Matera
Molecular Aspects of Medicine|March 8, 2022
Molecular aspects of asthmaMario Cazzola, Maria Gabriella Matera
Handbook of Experimental Pharmacology|October 28, 2016
Muscarinic Receptor AntagonistsMaria Gabriella Matera, Mario Cazzola
Chest|October 7, 2018
POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? YesMario Cazzola, Maria Gabriella Matera
Pageof 33

Showing results (21-30 of 324) with videos related to

Sort By:
Pageof 33
Therapeutic Advances in Respiratory Disease|January 7, 2009
Safety of long-acting beta2-agonists in the treatment of asthmaMario Cazzola, Maria Gabriella Matera
Therapeutic Advances in Respiratory Disease|January 7, 2009
Cough and asthma: the role of inhaled corticosteroids and beta2-agonistsMario Cazzola, Maria Gabriella Matera
Chest|August 7, 2008
To add, or not to add an inhaled corticosteroid in moderate COPD: that is the questionMario Cazzola, Maria Gabriella Matera
Expert Opinion on Pharmacotherapy|October 21, 2014
Triple combinations in chronic obstructive pulmonary disease - is three better than two?Mario Cazzola, Maria Gabriella Matera
Chest|May 4, 2012
Lung blood flow must be considered when prescribing a long-acting β2-agonist/inhaled corticosteroid combinationMario Cazzola, Maria Gabriella Matera
Respiratory Medicine|November 26, 2022
Clinically important deterioration: a composite tool for managing patients with COPDMario Cazzola, Maria Gabriella Matera
Chest|January 14, 2004
Long-acting bronchodilators are the first-choice option for the treatment of stable COPDMario Cazzola, Maria Gabriella Matera
Molecular Aspects of Medicine|March 8, 2022
Molecular aspects of asthmaMario Cazzola, Maria Gabriella Matera
Handbook of Experimental Pharmacology|October 28, 2016
Muscarinic Receptor AntagonistsMaria Gabriella Matera, Mario Cazzola
Chest|October 7, 2018
POINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? YesMario Cazzola, Maria Gabriella Matera
Pageof 33